{"nct_id":"NCT00371345","title":"Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer","status":"COMPLETED","status_verified_date":"2011-04","start_date":"2006-12","start_date_type":null,"primary_completion_date":"2009-03","primary_completion_date_type":"ACTUAL","completion_date":"2009-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}